Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 24, 2026.

Moringa oleifera: An Updated Comprehensive Review of Its Pharmacological Activities, Ethnomedicinal, Phytopharmaceutical Formulation, Clinical, Phytochemical, and Toxicological Aspects

Ashutosh Pareek, Malvika Pant, Madan Mohan Gupta and 5 more

International Journal of Molecular Sciences · 2023 · Review · CC BY

doi:10.3390/ijms24032098

Abstract

Moringa oleifera, also known as the “tree of life” or “miracle tree,” is classified as an important herbal plant due to its immense medicinal and non-medicinal benefits. Traditionally, the plant is used to cure wounds, pain, ulcers, liver disease, heart disease, cancer, and inflammation. This review aims to compile an analysis of worldwide research, pharmacological activities, phytochemical, toxicological, and ethnomedicinal updates of Moringa oleifera and also provide insight into its commercial and phytopharmaceutical applications with a motive to help further research. The scientific information on this plant was obtained from various sites and search engines such as Scopus, Pub Med, Science Direct, BMC, Google Scholar, and other scientific databases. Articles available in the English language have only been referred for review. The pharmacological studies confirm the hepatoprotective, cardioprotective, and anti-inflammatory potential of the extracts from the various plant parts. It was found that bioactive constituents are present in every part of the plant. So far, more than one hundred compounds from different parts of Moringa oleifera have been characterized, including alkaloids, flavonoids, anthraquinones, vitamins, glycosides, and terpenes. In addition, novel isolates such as muramoside A&B and niazimin A&B have been identified in the plant and have potent antioxidant, anticancer, antihypertensive, hepatoprotective, and nutritional effects. The traditional and nontraditional use of Moringa, its pharmacological effects and their phytopharmaceutical formulations, clinical studies, toxicity profile, and various other uses are recognized in the present review. However, several traditional uses have yet to be scientifically explored. Therefore, further studies are proposed to explore the mechanistic approach of the plant to identify and isolate active or synergistic compounds behind its therapeutic potential.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 24, 2026. Paragraph numbers are ours, so an answer can point at one.

1. Introduction

Moringa oleifera (M. oleifera), the “miracle tree”, thrives globally in almost all tropical and subtropical regions, but it is believed to be native to Afghanistan, Bangladesh, India, and Pakistan. The Moringa family comprises 13 species (M. oleifera, M. arborea, M. rivae, M. ruspoliana, M. drouhardii, M. hildebrandtii, M. concanensis, M. borziana, M. longituba, M. pygmaea, M. ovalifolia, M. peregrina, M. stenopetala), of which M. oleifera has become well known for its use in nutrition, biogas production, fertilizer, etc.,. Moringa has the unique property of tolerating drought. Studies have shown that M. oleifera is among the cheapest and most reliable alternatives for good nutrition. Nearly all parts of the tree are used for their essential nutrients. M. oleifera leaves have a high content of beta-carotene, minerals, calcium, and potassium. Dried leaves have an oleic acid content of about 70%, which makes them suitable for making moisturizers. The powdered leaves are used to make many beverages, of which “Zija” is the most popular in India. The bark of the tree is considered very useful in the treatment of different disorders such as ulcers, toothache, and hypertension. Roots, however, are found to have a role in the treatment of toothache, helminthiasis, and paralysis. The flowers are used to treat ulcers, enlarged spleen, and to produce aphrodisiac substances. The tree is believed to have incredible properties in treating malnutrition in infants and lactating mothers. The present review aims to sum up the updated insight regarding the pharmacological activities, worldwide research analysis, toxicological, phytochemical, and ethnomedicinal properties of M. oleifera.

2.1. Article Eligibility Criteria

In the framework of searching for study material, the following keywords were used: “Moringa oleifera”, “pharmacology M. oleifera”, “phytochemistry M. oleifera”, “ethnobotanical applications M. oleifera”, “toxicology M. oleifera”, and other combinations of terms such as biochemical constituents, taxonomic classification, geographical distribution, and plant formulation to search relevant peer-reviewed journals in various scientific databases such as Scopus, PubMed, Springer, Google scholar, and Wiley. Articles available in the English language have only been referred for review. Articles were analyzed by reading the title and abstracts of the articles found, which clearly indicated that they were all relevant.

2.2. Software and Techniques Used

Chemical structures identified in the plants were searched in the Webbook, Chemspider, and PubMed databases, and at the same time, the identified structures were drawn using Chem Draw (version 12.0.2). VOS Viewer software (1.6.18) was used to generate the map of global collaboration between countries. Global country boundaries (GIS layers) were obtained from an open-source web platform (DIVA-GIS) for geographic mapping. Spatial techniques were used with ArcGIS 10.1 to map M. oleifera indigenous and introduced countries and research activities in each country.

3. Worldwide Research and Collaboration

A country-specific research database on M. oleifera was extracted from Scopus, and the data were linked directly to the country shapefile using the “connect field” function in the GIS environment for geospatial mapping. The analyses revealed that scientists from about 15 countries had published more than 100 research papers during the period 2000–2022. Among which India was the most prolific country (n = 1083), followed by Nigeria (n = 441), Brazil (n = 383), Egypt (n = 361), China (n = 331), Indonesia (n = 327), Pakistan (n = 281), South Africa (n = 272), Malaysia (n = 260), the United States (n = 214), Saudi Arabia (n = 205), Mexico (n = 163), Thailand (n = 127), and Italy (n = 105), (Figure 1).

International studies on M. oleifera involve the collaboration of scientists from countries such as India, China, Egypt, Saudi Arabia, Cuba, Australia, the United States, Nigeria, and Portugal, which is indicated by circles in the map (Figure 2). The analysis shows that many articles were published in the past decade, indicating the growing interest of researchers in this plant worldwide.

4. Taxonomical Classification

The plant M. oleifera belongs to the Kingdom: Plantae; Sub kingdom: Tracheobionta; Super division: Spermatophyta; Division: Magnoliophyta; Class: Magnoliopsida; Sub class: Dilleniidae; Order: Capparales; Family: Moringaceae; Genus: Moringa; Species: oleifera.

5. Morphology

The tree grows rapidly in loamy and well-drained sandy soils, preferring a height of 500 m above sea level. Normally, the tree is small to medium in size, the leaves are naturally trifoliate, the flowers are born on an inflorescence 10–25 cm long, and the fruits are usually trifoliate and commonly referred to as “pods”. The trunk usually grows straight but is occasionally poorly formed, the branches are usually disorganized, the canopy is umbrella-shaped; the brown seeds have a semi-permeable hull, and each tree has a capacity of about 15,000–25,000 seeds per year.

6. Botanical and Geographical Distribution

M. oleifera is widely distributed worldwide, but its indigenous origin is in India, Arabia and the East Indies. It is common in Asia, Africa, the Caribbean, Latin America, the Pacific Islands, Florida, Madagascar, Central America, Cuba, the Philippines, Ethiopia, and Nigeria. The history of the plant explains that M. oleifera was introduced from India to Africa, Southeast Africa, and the Philippines in ancient times (Figure 3). It requires tropical and subtropical regions and grows at a temperature of about 25–35 °C. M. oleifera is a deciduous type of tree typically grown in tropical and subtropical regions across the globe. It grows best in indirect sunlight and without waterlogging, and the soil should be slightly acidic to alkaline. The tree begins to bear fruit at 6 to 8 months of age. Commercially, it is grown in different countries such as Africa, Mexico, Hawaii, and South America, but due to different soil conditions, the nutrient content varies from country to country.

7. Ethnomedicinal/Traditional Properties

People worldwide have included M. oleifera in their diet since ancient times because of its vital therapeutic values (Table 1). Various medicines made from the plant are said to have ethnomedicinal properties for curing diseases and have been used for centuries. Approximately every part (leaf, pod, bark, gum, flower, seed, seed oil, and root) of this plant has been used to treat one disease or another. Uses of M. oleifera are observed in pathological alterations such as antihypertensive, anti-anxiety, anti-diarrheal, and as a diuretic. Moringa is also used to treat dysentery and colitis. A poultice made from Moringa leaves is a quick remedy for inflammatory conditions such as glandular inflammation, headache, and bronchitis. The pods treat hepatitis and relieve joint pain. The roots are conventionally used to treat kidney stones, liver diseases, inflammation, ulcers, and pain associated with the ear and tooth. The bark of the stem is used to treat wounds and skin infections. Indians use the gum extracted from this plant to treat fever, and it is also used to induce abortions. The seeds of the plant act as a laxative and are used in the treatment of tumors, prostate, and bladder problems. The seeds show promise for the treatment of arthritis by altering oxidative stress and reducing inflammation. Preparations from the plant leaves benefit nursing mothers and malnourished infants and improve the general health of the population. The leaves have been useful for patients suffering from insomnia and treating wounds. Moringa is used incredibly extensively in the cosmetic industry nowadays, and in ancient Egyptian history, it was similarly used for preparing dermal ointments.

8. Pharmacological Uses

Recent pharmacological studies have revealed that different extracts of M. oleifera exhibit different pharmacological activities, such as antimicrobial, antifungal, anti-inflammatory, antioxidant, anticancer, fertility, wound healing, and other pharmacological activities mentioned below (Table 2).

8.1. Antimicrobial and Antifungal Activity

M. oleifera ethanolic root extract contains a compound N-benzylethyl thioformate (an aglycone of deoxyniazimincin) responsible for the antimicrobial and antifungal effect toward an extensive array of microbes and fungi. M. oleifera methanolic leaf extract may exert inhibition of urinary tract infections caused by Gram-negative and Gram-positive bacteria such as Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, and Staphylococcus saprophyticus.

The inhibitory effect of extracts from leaves, seeds, and stems of M. oleifera has been specified in various fungal strains such as Aspergillus flavus, Aspergillus terreus, Aspergillus nidulans, Rhizoctonia solani, Aspergillus niger, Aspergillus oryzae, Fusarium solani, Penicillium sclerotigenum, Cladosporium cladosporioides, Trichophyton mentagrophytes, Penicillium species, Pullarium species. M. oleifera seeds have active components 4-(alpha-L-rhamanosyloxy) benzyl isothiocyanates, which are believed to be responsible for their antimicrobial activity. The juice of Moringa leaves also showed potential against human pathogenic bacteria. The methanolic leaf extract has nearly 99% inhibition against Botrytis cinerea (a necrotrophic plant fungus).

The fruit of M. oleifera contains alkaloids, flavonoids, and steroids, which have an inhibitory effect against the culture of Candida albicans by either denaturing the protein or inhibiting the germination of spores through the steroid ring they contain.

Strong inhibitory effects of moringa seed kernel extract were observed for Bacillus cereus, Staphylococcus aureus, Mucor species, and Aspergillus species. However, it was less effective against P. aeruginosa and E. coli. This indicated that, except for E. coli and P. aeruginosa, moringa seed kernel extract might be utilized to treat infections caused by these species. A recent study has been conducted, which states that only apolar extract obtained from seeds of M. oleifera showed anti-microbial activity against Gram-positive bacteria.

8.2. Anti-Inflammatory Activity

A significant anti-inflammatory effect was observed in different parts of M. oleifera (leaf, pods, flowers, and roots). It was observed that the isolated compound (4-[2-o-Acetyl-alpha -l-rahamnoslyloxy) benzyl] thiocynate from Moringa possessed nitric oxide inhibitory activity and was subsequently found to be effective in Raw264.7 cell lines. A compound derived from M. oleifera roots, known as aurnatiamide acetate and 1,3-dibenzylurea, inhibited TNF-α production. Active compounds such as tannins, phenols, alkaloids, flavanoids, carotenoids β-sitosterol, vanillin, and moringin have anti-inflammatory properties. The M. oleifera fruit extract blocked nuclear factor kappa B (NF κB) translocation, and the chloroform extract was found to be cytotoxic at high concentrations (500–1000 µg/mL). M. oleifera leaves extract was used in mice for treating atopic dermatitis in human keratinocytes and was found to be effective in reducing the expression of mannose receptor mRNA, thymic stromal lymphopoietin, and retinoic acid-related orphan receptor γT in ear tissues (Figure 4).

8.3. Oxidative Stress

The results of M. oleifera were observed in methotrexate-induced mice. The study aimed to look into a probable palliative effect of M. oleifera extract on mice. The mice received the extract one week before administering methotrexate injection, and this treatment was continued for 12 days. The result showed that pretreatment with an extract of M. oleifera on mice poisoned with methotrexate could protect them from oxidative stress.

The antioxidant activity of ethanolic extract M. oleifera stems exhibited a protective effect against epidermal oxidative stress injury induced by H2O2 in keratinocytes. The result displayed that the stems showed antioxidant potential, and, therefore, can be used as an excellent and preventive source in animal epidermal oxidative stress injury.

The research investigated the antioxidant potential of Moringa leaves against diclofenac sodium-induced liver toxicity in animals. The researchers concluded that the extract was significantly effective against diclofenac-induced liver toxicity and, therefore, can be considered liver protective.

8.4. Anti-Oxidant Activity

Bioactive compounds such as glycosylates, isothiocyanates, thiocarbamates, flavonoids, and certain other compounds from Moringa pods have been investigated for reactive oxygen spices. The aqueous extract has been shown to be a potent free radical scavenger against free radicles. Previous studies suggest that the antioxidant potential might be due to kaempferol, which is mainly found in plant leaves. The synergistic outcome of Moringa was observed with piperine and curcumin on oxidative stress induced by beryllium toxicity in Wistar rats. The alcoholic extract of the plant reduced glucose-induced cataractogenesis in isolated goat eye lenses by controlling GSH levels. Myricetin, derived from the Moringa seed extract, has proved to be a better antioxidant than BHT (butylated hydroxytoluene) and alpha-tocopherol. M. oleifera leaf extract and compounds, such as isoquercetin, astragalin, and crypto-chlorogenic acid, help lower ROS in HEK-293 cells. Moringa is also helpful in reducing plasma monoaldehyde (MDA) levels in fasting plasma glucose (FPG) concentration in healthy volunteers compared to the individuals fed with warm water. A dose-dependent upsurge in GSH and reduced MDA levels were observed with alcoholic extract of the plant without toxic effect till 100 mg/kg (Figure 4).

8.5. Anti-Cancer Activity

Several parts of moringa (fruits, leaves, flowers, stems) have been shown to be beneficial against cancer, a deadly disease. The isolated compounds thiocarbamate and isothiocyanate from moringa act as inhibitors of tumor cells. The dichloromethane fraction was found to be cytotoxic for MCF7 breast cancer cells. Niazimincin has been projected as an effective chemopreventive agent in chemical carcinogenesis. Alcoholic and hydro-methanolic extracts of fruits and leaves have shown significant tumor growth retardation in the melanoma mouse model. Soluble cold distilled water from Moringa inhibited tumor cell growth and reduced ROS (reactive oxygen species) in cancer cells. A recent study based on computational modelling suggests that M. oleifera contains rutin with the highest binding affinity with BRAC-1 (Breast Cancer Gene-1).

8.6. Fertility and Anti-Fertility Activity

Adding to the list of beneficial effects of Moringa, the various parts of the plant possess fertility and abortion-inducing properties. The aqueous extract at a 200 and 400 mg/kg dose has been found to be more abortifacient and anti-fertility effects. Recent studies on hot and cold extracts of leaves of M. oleifera propose that ingestion of Moringa before, after, and during pregnancy may lead to adverse fetal developmental outcomes by causing rigorous contraction of the uterine wall.

8.7. Hepatoprotective Activity

Among the numerous flavonoids (quercetin, kaempferol, isoquercetin, rhamnetin, etc.,) present in Moringa, quercetin in Moringa flowers is thought to be accountable for the hepatoprotective effect. Methanolic extract at low dose showed changes in hepato-renal and hematological profile with significant changes in serum aminotransferase concentration, plasma cholesterol level, alkaline phosphate, bilirubin, and serum LPO levels. However, the higher dose of the extract altered total bilirubin, blood urea nitrogen, and non-protein nitrogen levels and decreased the clotting time. Liver injuries induced by acetaminophen in Sprague-Dawley rats, where the standard drug taken was silymarin, Moringa showed similar hepatoprotective properties in these rats by dropping the levels of AST, ALT, and ALP. The seeds were also found to be effective against carbon tetrachloride-induced liver fibrosis, as evidenced by a reduction in serum aminotransferase activity and globulin levels. Treatment with this plant extract for about 21 days regularly as diet significantly reduced liver injury, and this effect was found due to alkaloid, quercetin, kaempferol, flavonoids, ascorbic acid, and benzyl glucosinolates in this plant.

8.8. Cardiovascular Activity

The freeze-dried aqueous and alcoholic extract of M. oleifera showed cardioprotective activity in animals induced with myocardial infarction by isoproterenol. Chronic treatment of M. oleifera was effective on isoproterenol-induced hemodynamics and improved the levels of enzymes such as SOD, catalase, lactase dehydrogenase, glutathione peroxidase, and creatine kinase. Butanolic extract has been proven to be a rich antioxidant source in rats with cardiac necrosis induced with isoproterenol. Moreover, it was found to significantly reduce inflammatory levels and myocardial necrosis due to the presence of the compound N-α-rhamnopyranosyl vincosamide. Moringa leaves significantly lowered cholesterol levels by showing a protective effect on hypertensive rats. The active constituents believed to be responsible for this activity were identified as niazirmin A, niazirimin B, and niazimincin.

8.9. Anti-Ulcer/Gastroprotective Activity

Bisphenols and flavonoids found in moringa leaves showed a reduced level of ulcer index, duodenal ulcer, and stress ulcer in the ibuprofen-induced gastric ulcer model. Moringa extract was shown to significantly reduce free radicals and neutralize the acidic behavior of gastric juice and have a protective effect on the development of gastric ulcer. The presence of flavonoids in the plant has been shown to have a protective effect on ulcer formation by increasing capillary resistance and improving microcirculation, resulting in less cell injury.

8.10. Analgesic/Antipyretic Activity

Moringa leaf extract shows analgesic activity in almost all tree parts in central and peripheral animal models. Multiple factions of alcoholic extracts such as petroleum ether, n-butanol, ethyl acetate, and dimethyl ether were found to have potent analgesic activity compared to standard aspirin. At a dosage of 30–300 mg/kg, the polar and non-polar extract of leaves showed a remarkable drop in prostaglandin and bradykinin levels compared to the seed and root extract in a nociceptive study of formalin-induced paw edema. The ether and ethyl acetate fractions of the seeds were studied in a hyperpyrexia model, keeping paracetamol as standard 200 mg/kg, and the extract proved to have the best antipyretic activity among all.

8.11. Neuropharmacological Activity

Previous results have proved that leaves extract reestablishes levels of monoamine in the brain and is very helpful in Alzheimer’s disease, while the in vitro activity of the ethanolic extract of the leaves showed an anticonvulsant effect on dopamine and norepinephrine levels, locomotor activity, and serotonin (5HT) in the brain in penicillin-induced convulsions. The methanolic root extract in mice induced by pentobarbital sodium and diazepam has remarkable sedative effects on the CNS by improving sleep duration. The toluene acetate fraction of the methanolic extract proved its potency as a possible nootropic agent. The leaves have shown good anticonvulsant activity in a phenyl tetrazoline and maximal electric shock-induced model using male albino mice. The aqueous extract of the roots blocked the epileptic seizures induced by penicillin in adult albino rats. The ethanolic leaves extract exhibited anxiolytic properties, which were confirmed in behavioral experiments using the actophotometer and the rotarod device, respectively (Figure 5).

8.12. Neuropathic Pain

The broad spectrum of phytoconstituents of the leaves extract of Moringa has led researchers to develop a herbal alternative for treating chronic neuropathic pain caused by constriction. The need to limit conventional analgesics for this disease. Diabetic rats inflicted with neuropathic pain caused by chronic constriction were used for the study. Tests conducted before and after treatment with moringa leaves showed that they significantly altered the neuropathic pain condition in diabetic rats. It suggests that the drop in oxidative stress might be the underlying mechanism in treating neuropathic pain and thus could be used as an effective novel source for the same.

A research team explored the bio-guided fractions of Moringa seed extract on a diabetes-induced neuropathic pain model. After conducting various oxidative and other experimental studies on induced and treated rats, the team concluded that the extract-treated rats exhibited reasonable glycemic control and antinociceptive properties and proved to be a powerful neuroprotective agent with a high margin of safety (Figure 5).

8.13. Wound Healing Effect

A significant effect in studies on wound healing after incision or excision was demonstrated for ethyl acetate, and water extract of M. oleifera leaves at a 300 mg/kg dose. Studies reported that in preclinical studies, leaves, seeds, and dried pulp extracts have shown effective enhancement of wound closure, granuloma rupture strength, and reduction of skin rupture strength in the scar area. Leaf extracts have shown promising results in diabetic animals by improving the downregulation of inflammatory markers and increasing the vascular endothelial growth factor level in the injured tissue. Compounds present in aqueous extract have shown a considerable effect on diabetic foot ulcers by downregulating the levels of various inflammatory markers. The researcher conducted an in vitro assay to select the standardized extract with the highest potency, which was then converted into a film for wound healing. The result showed that the aqueous extract had the maximum cell proliferation and migration properties among the different extracts.

8.14. Immunomodulatory Activity

Methanolic extract of the plant contains active constituents such as isothiocyanate and glycoside cyanide, which exhibit immunostimulatory activity and effectively enhance immunity. The recent review paper suggests that various bioactive compounds have been used to treat various immune-related disorders such as cancer, hypertension, and diabetes, thereby enhancing host immunity.

8.15. Hematological Activity

M. oleifera has demonstrated its significant benefits in hematological activities. A randomized, double-blind study suggests that aqueous leaf extract effectively improves women’s low hemoglobin levels (8–12 g/dL). Another study showed that M. oleifera leaves, when taken for 14 days by healthy volunteers, significantly improved platelet counts.

8.16. Anti-Obesity Activity

In a study, oral treatment with leaf powder of M. oleifera for a duration of nearly 49 days was found to significantly reduce body mass index (BMI) in rats suffering from hypercholesterolemia. The mechanistic approach behind this was the downregulation of mRNA expression of the hormones resistin and leptin and the concomitant increase in regulation of the gene adiponectin in rats. A recent study revealed the mechanistic approach for the anti-obesity effect of M. oleifera. The plant significantly improved lipid profile by reducing body weight. It also regulated adipogenesis-related genes, increased glucose tolerance, and decreased levels of hormones such as vaspin, leptin, and resistin (Figure 6).

8.17. Anti-Allergic Activity

The ethanolic seeds extract reduced histamine release and also suppressed the anaphylaxis induced by anti-immunoglobulin G. The mechanism underlying this effect may be the membrane-stabilizing potential of mast cells in an oval albumin sensitization model.

8.18. Anti-Diabetic Activity

Moringa leaves showed excellent results in the glucose tolerance of Wistar and Goto-Kakizaki rats and also lowered blood glucose levels. The aqueous extract showed an antidiabetic effect in rats by controlling blood glucose levels, protein, sugar, and hemoglobin. The leaves of the plant were found to lower glucose levels within three hours of intake, but not more than the standard drug glibenclamide. Moringa seeds, when administered orally, contain insulin-like proteins that have antigenic epitopes such as insulin and exhibit antihyperglycemic activity. Leaf extracts of the plant also have antidiabetic activity as they increased CAT and MDA levels, reduced FPG levels, hemoglobin levels, LDL-C, and VLDL-C in type 2 diabetic patients and, most importantly, increased insulin levels in healthy subjects. The seed extract of the plant reduced LPO levels and amplified the antioxidant effect in mice induced with streptozotocin, the seed extract was also able to reduce IgG, IgA, and IL -6 parameters and pancreatic β-cell activity, and it was suggested that the bioactive compound responsible for this effect were quercetin, kaempferol, glucomoringin, chlorogenic acid, and isothiocyanates.

8.19. Diuretic Activity

The alcoholic and aqueous root extract of M. oleifera significantly affects calcium oxalate urolithiasis in male rats. This reduction was observed due to the decrease in the retention level of oxalates, calcium and phosphates as well as serum urea nitrogen, creatinine, and uric acid.

8.20. Angiotensin Converting Enzyme (ACE) Activity

Compounds such as niazimin-A, niazicin-A, and niaziminin-B are stated to be present in the M. oleifera plant extract. These compounds were found to have potent antihypertensive activity when targeted to (ACE), an important enzyme of the renin-angiotensin system. The researchers observed this activity by protein–ligand docking and found that the compounds have a high affinity for the angiotensin-converting enzyme compared with captopril and enalapril (standard drug). The angiotensin enzyme rennin plays a prominent role in regulating blood pressure and leading to diseases such as hypertension, kidney disease, and other cardiovascular diseases. The study found that the role of M. oleifera with two other plants (Azadirachta indica and Hibiscus sabdariffa) inhibited the enzyme with percentage inhibition (71.8%, 74%, and 73.4%) compared to standard drugs (captopril and enalapril). The compound responsible for this activity of Moringa was termed β-sitosterol.

8.21. Anti-Venom Effect

The leaves of the plant extract have been shown to be effective against the venom of Naja Nigricollis (a snake species) in rats. This snake’s venom contains potent neurotoxins that cause the degradation of phospholipids at the plasma membrane, affecting the normal neurotransmission process and causing hemolysis and hemorrhage. The results showed that Moringa extract effectively cured acute anemia, and a remarkable increase in micronucleated polychromatic erythrocytes was observed in rats treated with M. oleifera.

8.22. Cytotoxicity Effect

The cytotoxic potential of M. oleifera on human mesenchymal myeloma cell lines is observed in methanolic extract. The results of the extracts showed a higher ID50 value than other extracts. The researchers also found that the alkaloids and flavonoids contained in the plant showed some similarity to vincristine and vinblastine by random experiments. Therefore, the plant can be recommended for the herbal treatment of myeloma patients.

It was found that the ethanolic leaves extract of M. oleifera contains active constituents that can alleviate cyclophosphamide-induced testicular toxicity by promoting genes associated with the functional integrity of spermatozoa and enlargement of DNA in spermatogonia. Therefore, the administration of the extract not only improved blood and intestinal hormone levels but also modulated the expression of genes responsible for Sertoli and spermatogonial cells.

9. Toxicity

Various experimental procedures were conducted to evaluate the toxic potential of the plant. A random selection of female non-pregnant Wistar albino rats was conducted with an oral dose of 2000 mg/kg aqueous methanol solution. Blood samples were collected, and the ALT, AST, and total bilirubin content were determined. The outcome of the study suggested that the lethal dose of the aqueous extract was higher than 2000 mg/kg in female rats.

A similar study was also conducted in Sprague-Dawley rats to evaluate the acute toxic potential of Moringa leaf powder. The experiment also found that oral administration of dried leaves up to 2000 mg/kg had no harmful or lethal effect on the human body.

The toxicity of M. oleifera seeds in rats was observed at acute and subacute levels (methanolic extract). Acute toxicity was seen at a dose of 4000 mg/kg, whereas mortality was observed at a dose of 5000 mg/kg. Therefore, in a nut shell, it could be summarized that the seed extract could be safe for nutritional use.

Experiments conducted for acute and subacute studies indicated that the stem bark extract did not cause any toxic effect in the acute and subacute toxic studies up to 2000 mg/kg. Therefore, the researchers concluded that the stem bark of M. oleifera can be considered non-toxic when administered orally.

The subacute toxicity test at a dose of 250, 500, and 1500 mg/kg was performed for 60 days. The result showed that the lethal dose was 1585 mg/kg without significant alterations in sperm quality, biochemical, and hematological parameters compared to the control group.

The acute toxic study (5000 mg/kg) and subacute (40–1000 mg/kg) results showed no adverse reaction during these studies. However, increased ALT, ALP, and lower creatinine levels were observed. Therefore, it could be concluded that consumption is safe, but intake should not surpass 70 gm/day to prevent cumulative toxicity.

10. Clinical Trials

To date, 25 clinical studies have been conducted on M. oleifera, fifteen of which have been completed. Nine of these fifteen studies addressed M. oleifera as part of a diet, while the remaining studies were limited to disease-specific drug interventions. Overall, the studies demonstrated the efficacy of using moringa for conditions such as malnutrition, chronic kidney disease, HIV infection, and reproductive health.

A clinical study highlighted the significant role of M. oleifera as an anti-asthmatic agent. In this study, researchers used seed kernels of M. oleifera to treat symptoms of bronchial asthma. Candidates were selected based on inclusion and exclusion criteria, with respiratory parameters and blood samples recorded before and at the end of three weeks of treatment with M. oleifera. The extract was administered to patients in the form of dried powder at a dose of 3 g twice daily for three weeks, and they were instructed to take water with the powder. Symptoms were graded as severe, moderate, and mild on a point table. The results indicate that symptoms and respiratory functions decreased; M. oleifera seeds can effectively treat bronchial asthma.

11. Phytopharmaceutical Formulations

Plant extracts have always attracted researchers’ attention for producing various pharmaceutical products. This process usually involves the production of medicinal products characterized by two things: first, the production of a stable product, and second, patient compliance. The advantage of Moringa plant extracts is that it appears to be exceedingly safe at the doses and in the amounts commonly utilized for therapeutic efficacy. M. oleifera has been widely accepted in the research area, and scientists have used an array of approaches to develop various formulations. The various phytoformulations prepared using M. oleifera are tabulated below (Table 3).

12. Miscellaneous Uses

A study was performed on M. oleifera using the HPLC-based cyclo condensation method. Astragalin and isothiocyanates were used as markers for standardization of the plant. The conclusive result of the study suggests that the standardized method might be useful for assessing the quality of the development of cosmetic and natural health products.

The extract of M. oleifera leaves was helpful in eliminating the adverse effects of neem oil, which is used in aquaculture as an insecticide to control predators and parasites of fish fry. The researchers concluded that the extract of M. oleifera leaves eliminated the oxidative stress and toxicity caused by neem oil.

The lower yield of okra (Abelmoschus esculentus) was studied. The low production of these crops was due to infestation by pests and insects and poor soil nutrient content. In order to improve production conditions, different chemical pesticides were used, which brought further environmental risks. The use of M. oleifera aqueous leaf extract at different concentrations (1:30 and 1:40) proved beneficial for okra.

The efficacy of M. oleifera leaf and root extract was evaluated as a plant growth regulator and biopesticide in the wheat harvest. The researcher used different concentrations (5, 10, 12.5, 25% w/w, w/v, v/v) of Moringa leaf and root extract at different stages of the wheat plant. Significant plant growth was observed, resulting in increased yield and a decrease in aphid invasion.

M. oleifera is rich in macronutrients and micronutrients, vitamins, phytohormones, alkaloids, and flavonoids, which make this plant a multipurpose plant. Recent research has shown that Moringa extract is also helpful in tolerance to abiotic and biotic stress under stressful environmental conditions.

The therapeutic effect of bioactive constituents (flavonoids, alkaloids, tannins, isothyocyanin and beta-sitosterol) present in M. oleifera has been reported in chronic diseases such as hyperlipidemia, hypertension, hepatoprotective, anti-cancer, Alzheimer’s disease, Parkinson’s disease.

The combined effect of M. oleifera and praziquantel in rats was studied by a group of researchers. The seeds and leaves of M. oleifera were considered to evaluate their bioavailability with praziquantel and also the in vivo effects of the same were observed on Taenia crassiceps. The study showed that the combined action of both had a significant amount of cytocidal activity compared to the rats, which were only administered with praziquantel.

A variety of bioactive nutrients, such as flavonoids and vitamins, is available in the M. oleifera plant. The in vitro study conducted by a group of researchers focused on bioactive compounds that make up the nutritional potential of plants. The conclusive statement of the researcher revealed that the high content of proteins, lipids, and sulfur-containing amino acids and the relative lack of toxic components make moringa a great nutritional alternative for humans.

The bioactive isolate palmitic acid from the leaf extract of Moringa has been attributed to broad therapeutic benefits. A team of researchers studied this isolate against a wide range of microbial and fungal strains. The results showed that it had the highest zone of inhibition for both fungal and microbial strains.

The polyphenols and flavonoids present in M. oleifera to scavenge free radicals could be useful in developing an anticancer drug delivery system. Nanoparticle technology was used to incorporate Moringa extract as a drug carrier. Treatment of HeLa cell lines with a single dose of the plant showed that the composite film of the plant extract was efficient in killing malignant cells compared to other isolated and purified phytocomponents on the market.

The bioactive components of M. oleifera inhibit the inflammatory markers in lipopolysaccharide-induced human macrophages. The induced macrophages were treated with M. oleifera extract. Thereafter the treated cells were tested for their anti-inflammatory and cellular mechanism. The results revealed that the extract suppressed mRNA expression of IL -6, IL -1, NF-κB (P50), PTGS2, and TNF-α. At the same time, the inhibition of phosphorylation of IκB-α and nuclear factor (NF)-κB was also observed in the study. The researchers’ final statement suggests that the blocking of NF-κB and IκB-α may be the reason for the inhibition of inflammation.

Apart from its wide use in preventing and curing various human diseases, Moringa is known for a number of non-medicinal uses, chief among which is its use for poultry, especially in curing viral infections (Newcastle Disease Virus) and other parasitic and bacterial diseases that cause mortality in animals. The plant also serves as an important growth promoter for farmers in the production of tomatoes, peanuts, corn, and wheat in their early vegetative stages. Environmentally friendly biopesticides are produced from this plant, which is cheap and easily available and helps in curing various plant diseases. Studies have shown that the total crop production increased by 20–35% by using M. oleifera leaf extract, which is a good sign for increasing agricultural growth at a minimal cost. The aqueous extract of M. oleifera is a source of various minerals and growth promoters (indole acetic acid, gibberellins, cytokines). It thus can be used as an effective plant biostimulant that could be a simple alternative to the artificial fertilizers and pesticides available in the market. The methanolic extract of the plant is found to be rich in potassium, calcium, carotenoid, phenols, and zeatin, and when three sprays of this extract are applied on the oilseed rape plant, it is observed that the pods, twigs, height, and number of seeds increase significantly compared to the untreated control group. The ability of the plant to resist drought is due to the plant hormone “zeatin”, which is present in large quantities in the methanolic extract, so the plants exposed to such climatic conditions when sprayed with the methanolic extract of Moringa showed improved growth characteristics compared with well-watered plants. The tree is efficient in removing water hardness and is used by African tribes as a cheap source compared to chemical softeners. A study conducted by several groups found that treating river water in African countries with Moringa seeds reduced color and microorganisms by 90% and microorganism (Escherichia coli) levels by up to 95%. Previous reports indicated that a water sample treated with M. oleifera seeds reduced the hardness content of the water by 50–70%, which used to be 80.3 g L−1 CaCO3. It has also been shown to be an effective solution for treating turbidity, alkalinity, and dissolved organic carbon. It is suggested that Moringa could be, to some extent, an alternative to chemical alum used to remove water turbidity. Moringa is a good source for curing plant diseases and can be a good option for biopesticides. Since various plant pathogens affect the plants, Pythium debaryanum-a pathogen responsible for damping-off disease-can be cured by adding leaves to the soil. Nearly all plant part (fruits, flowers, leaves, seeds, roots) is believed to have different properties that can heal the body spiritually and psychologically.

13. Phytochemistry

Almost all parts of M. oleifera and its isolates have been studied for research. Based on the literature collected between 2010 and 2022, more than 90 compounds from the genus Moringa have been identified, many of which have therapeutic potential. The isolates fall into the category of proteins and amino acids, phenolic acids, carotenoids, alkaloids, glucosinolates, flavonoids, sterols, terpenes, tannins and saponins, fatty acids, glycosides, and polysaccharides (Table 4 and Table 5).

The leaves contain larger amounts of calcium, potassium, proteins, and amino acids such as arginine and histidine.

M. oleifera leaves contain a higher concentration of phenolic acids and flavonoids, including cinnamic acid, sinapic acid, syringic acid, gentisic acid, gallic acid, ferulic acid, protocatechuic acid, vanillin, caffeic acid, o- coumaric acid, p-coumaric acid and epicatechin are phenolic acids. In contrast, quercetin, catechin, myricetin, and kaempferol fall under the category of flavonoids having excellent therapeutic activity and are listed above in Table 2.

The carotenoid lutein is present in larger quantities in the leaves of M. oleifera. The therapeutic efficacy of the plant is due to the active constituents present in the plant leaves. The leaves of the plant revealed nearly thirty-five compounds by gas chromatography–mass spectrometry. Among the thirty-five isolated compounds, some important ones isolated in the leaves were palmitoyl chloride, cis-vaccenic acid, 5-O-acetyl-thio-octyl, pregna-7-dien-3-ol-20-one, γ-sitosterol, β-l-rhamnofuranoside, and tetradecanoic acid.

Two new alkaloids, marumoside A and marumoside B, were also isolated from M. oleifera leaves; another type of alkaloid, aurnatiamide acetate was isolated from M. oleifera roots. Moringin and moringinine are the two alkaloids present in the plant’s stem.

M. oleifera is a rich source of glucosinolates. The most abundant glucosinolate present in the species is 4-O-(α-L-rhamnopyranosyloxy)-benzyl glucosinolates, also known as glucomoringin.

A sterol isolate, β-sitosterol was found in seeds and leaves of M. oleifera. Another type of sterol glycoside β-sitosterol-3-O-β-D-galactopyranoside was extracted from M. oleifera bark.

An interesting category of diterpenes and terpenes is found in M. oleifera leaves. Among which Phytol is diterpene alcohol, a major component of chlorophyll, and is found abundantly in leaves of the plant. At the same time, terpenes and their derivatives are present in trace amounts (linalool oxide, farnsylacetone, isolongifolene α-ionene, and α- and β-ionone), whereas hexahydro-farnesyl acetone can be found in abundance.

Seed oil extract of M. oleifera commonly contains tannins and saponins, which are responsible for numerous pharmacological activities.

Fatty acids such as arachidic acid, octacosanoic acid, oleic acid, palmitic acid, stearic acid, linolenic acid, behenic acid, and paullinic acid are found in M. oleifera seeds.

Two glycosides, namely niazirin and niazirinin were extracted from the ethanolic extract of M. oleifera.

The exudate of the gum contains a large number of poly saccharides such as D-galactose, L-arabinose, D-xylose, L-rhamnose, D-mannose, and -glucuronic acid. The structure of some of the key phytoconstituents isolated from M. oleifera is shown in Figure 7.

14. Current Status

Moringa is a versatile plant with numerous benefits, and the current status of the plant suggests that it can be used in various pharmacological activities and their related formulations, biomedical applications, livestock, poultry, and fish production, enormously. Extensive research conducted in India, Nigeria, Brazil, and China during 2019–2022 has created a valuable resource for researchers worldwide. After an extensive study of this plant, it was found that M. oleifera has evolved to benefit humans in many ways. A large number of nutrients and phytoconstituents in this plant make it suitable for consumption by humans and animals. Due to its high anti-oxidant properties, it has become a pharmaceutical option for the production of formulations such as wound healing, anti-cancer, and anti-ageing etc. It is suitable not only for human use but also as a fertilizer in various forms extracted from M. oleifera. Besides its benefits, it also has severe toxic and abortifacient effects when taken in large quantities.

15. Conclusions and Future Perspective

The review summarizes various aspects of M. oleifera, including its worldwide research, ethnopharmacology, pharmacology activities, phytochemistry, phytopharmaceutical formulations, clinical studies, toxicology, and other miscellaneous parameters. The presence of alkaloids, phenolic acid, glycosides, sterols, glucosinolates, flavonoids, terpenes and fatty acids are responsible for the medicinal effects of M. oleifera. In addition, M. oleifera is also rich in compounds such as vitamins, micronutrients, and carotenoids which increase its medicinal value and consumption as a superfood. Pharmacological studies show that the active constituents of the plant have effectively cured various diseases such as neuropathic pain, cancer, hypertension, diabetes, obesity etc. Nevertheless, several phytochemicals have yet to be explored for their possible therapeutic benefits. In addition to its clinical use, the plant is also used as an effective biostimulant for farmers in their fields and has proven to be a cost-effective alternative. A literature survey suggested that much preclinical research has been carried out in the last few years. In the future, more clinical studies are required to investigate the efficacy of the plant in life-threatening diseases such as coronavirus outbreaks, an acquired immunodeficiency syndrome (AIDS), and various cancers. Moreover, further mechanism base studies are also proposed to explore the mechanistic approach of the plant to identify and isolate active or synergistic compounds. Overall, M. oleifera signifies its name, “Miracle tree,” and appears to be a phytopharmaceutical and functional food that, if consumed daily, can potentially treat various chronic diseases in humans and could be used by medical practitioners as a safer alternative to treat various ailments.

References 190

  1. 1.

    Fuglie L.J. Producing Food without Pesticides: Local Solutions to Crop Pest Control in West Africa. 1998;1-158.

    Not in our library

  2. 2.

    Gandji K., Chadare F.J., Idohou R., Salako V.K., Assogbadjo A.E., Glèlè R.L.K. Status and utilisation of Moringa oleifera Lam: A review. Afr. Crop Sci. J. 2018;26:137-156.

    Not in our library10.4314/acsj.v26i1.10

  3. 3.

    Chaudhary K., Chourasia S. Nutraceutical properties of Moringa oleifera: A review. EJPMR. 2017;4:646-655.

    Not in our library

  4. 4.

    Gopinath L.R., Jeevitha S., Gokiladevi T., Archaya S. Isolation and Identification of therapeutic compounds from Moringa oleifera and its antimicrobial activity. IOSR-JPBS. 2017;12:1-10.

    Not in our library

  5. 5.

    Kasolo J.N., Bimenya G.S., Ojok L., Ochieng J., Ogwal-Okeng J.W. Phytochemicals and uses of Moringa oleifera leaves in Ugandan rural communities. J. Med. Plant Res. 2010;20104:753-757.

    Not in our library

  6. 6.

    Anwar F., Ashraf M., Bhanger M.I. Interprovenance variation in the composition of Moringa oleifera oilseeds from pakistan. J. Am. Oil Chem. Soc. 2005;82:45-51.

    Not in our library10.1007/s11746-005-1041-1

  7. 7.

    Ansari M.M., Kumar S.D. Fortification of Food and Beverages with Phytonutrients. Public Health Nutr. 2012;2:241-253.

    Not in our library

  8. 8.

    Choudhary M.K., Bodakhe S.H., Gupta S.K. Assessment of the antiulcer potential of Moringa oleifera root-bark extract in rats. J. Acupunct. Meridian Stud. 2013;6:214-220.

    Not in our library10.1016/j.jams.2013.07.003

  9. 9.

    Posmontier B. The medicinal qualities of Moringa oleifera. Holist. Nurs. Pr. 2011;25:80-87.

    Not in our library10.1097/hnp.0b013e31820dbb27

  10. 10.

    Aekthammarat D., Pannangpetch P., Tangsucharit P. Moringa oleifera leaf extract lowers high blood pressure by alleviating vascular dysfunction and decreasing oxidative stress in L-NAME hypertensive rats. Phytomedicine. 2019;54:9-16.

    Not in our library10.1016/j.phymed.2018.10.023

  11. 11.

    Tayo G.M., Pone G.W., Komtangi M.C., Yondo G., Ngangout A.M., Mbida M. Anthelminthic Activity of Moringa oleifera Leaf Extracts Evaluated in Vitro on Four Developmental Stages of Haemonchus contortus from Goats. AJPS. 2014;5:1702-1710.

    Not in our library10.4236/ajps.2014.511185

  12. 12.

    Hannan M.A., Kang J.Y., Mohibbullah M., Hong Y.K., Lee H., Choi J.S., Choi I.S., Moon I.S. Moringa oleifera with promising neuronal survival and neurite outgrowth promoting potentials. J. Ethnopharmacol. 2014;152:142-150.

    Not in our library10.1016/j.jep.2013.12.036

  13. 13.
  14. 14.

    Mallenakuppe R., Homabalegowda H., Gouri M.D., Basavaraju P.S., Chandrashekharaiah U.B. History, Taxonomy and Propagation of Moringa oleifera-A Review. Int. J. Life Sci. 2019;5:2322-2327.

    Not in our library10.21276/ssr-iijls.2019.5.3.7

  15. 15.

    Guevara A.P., Vargas C., Sakurai H., Fujiwara Y., Hashimoto K., Maoka T., Kozuka M., Ito Y., Tokuda H., Nishino H. An antitumor promoter from Moringa oleifera Lam. Mutat. Res. 1999;440:181-188.

    Not in our library10.1016/s1383-5718(99)00025-x

  16. 16.

    Vimala G., Gricilda Shoba F. A review on Antiulcer Activity of Few Indian Medicinal Plants. Int. J. Microbiol. 2014;2014:519590.

    Not in our library10.1155/2014/519590

  17. 17.

    Popoola J.O., Obembe O.O. Local knowledge, use pattern and geographical distribution of Moringa oleifera Lam. (Moringaceae) in Nigeria. J. Ethnopharmacol. 2013;150:682-691.

    Not in our library10.1016/j.jep.2013.09.043

  18. 18.

    Swatią A., Virk A.K., Kumari C., Ali A., Garg P., Thakur P., Attri C., Kulshrestha S. Moringa oleifera—A never die tree: An overview. Asian J. Pharm. Clin. Res. 2018;11:57-65.

    Not in our library10.22159/ajpcr.2018.v11i12.28049

  19. 19.

    Gopalakrishnan L., Doriya K., Kumar D.S. Moringa oleifera: A review on nutritive importance and its medicinal application. Food Sci. Hum. Wellness. 2016;5:49-56.

    Not in our library10.1016/j.fshw.2016.04.001

  20. 20.

    Stohs S.J., Hartman M.J. Review of the Safety and Efficacy of Moringa oleifera. Phytother. Res. 2015;29:796-804.

    Not in our library10.1002/ptr.5325

  21. 21.

    Bhat S.K., Joy A.E. Antianxiety effect of ethanolic extract of leaves of Moringa oleifera in Swiss albino mice. Arch. Med. Health Sci. 2014;2:5-7.

    Not in our library

  22. 22.

    Misra A., Srivastava S., Srivastava M. Evaluation of antidiarrheal potential of Moringa oleifera (Lam.) leaves. J. Pharmacogn. Phytochem. 2014;2:43-46.

    Not in our library

  23. 23.

    Tahkur R.S., Soren G., Pathapati R.M., Buchineni M. Diuretic activity of Moringa oleifera leaves extract in swiss albino rats. J. Pharm. Innov. 2016;5:8-10.

    Not in our library

  24. 24.

    Woldeyohannes M.G., Eshete G.T., Abiye A.A., Hailu A.E., Huluka S.A., Tadesse W.T. Antidiarrheal and Antisecretory Effect of 80% Hydromethanolic Leaf Extract of Moringa stenopetala Baker f. in Mice. Biochem. Res. Int. 2022;2022:2090-2247.

    Not in our library10.1155/2022/5768805

  25. 25.

    Zhang Y., Peng L., Li W., Dai T., Nie L., Xie J., Ai Y., Li L., Tian Y., Sheng J. Polyphenol Extract of Moringa oleifera Leaves Alleviates Colonic Inflammation in Dextran Sulfate Sodium-Treated Mice. Evid. Based Complement. Altern. Med. 2020;2020:6295402.

    Not in our library10.1155/2020/6295402

  26. 26.

    Karadi R.V., Gadge N.B., Alagawadi K.R., Savadi R.V. Effect of Moringa oleifera Lam. root-wood on ethylene glycol induced urolithiasis in rats. J. Ethnopharmacol. 2006;105:306-311.

    Not in our library10.1016/j.jep.2005.11.004

  27. 27.

    Ghasi S., Nwobodo E., Ofili J.O. Hypocholesterolemic effects of crude extract of leaf of Moringa oleifera Lam in high-fat diet fed wistar rats. J. Ethnopharmacol. 2000;69:21-25.

    Not in our library10.1016/s0378-8741(99)00106-3

  28. 28.

    Paliwal R., Sharma V., Pracheta. A Review on Horse Radish Tree (Moringa oleifera): A Multipurpose Tree with High Economic and Commercial Importance. Asian J. Biotechnol. 2011;3:317-328.

    Not in our library10.3923/ajbkr.2011.317.328

  29. 29.

    Debnath S., Guha D. Role of Moringa oleifera on enterochromaffin cell count and serotonin content of experimental ulcer model. Indian J. Exp. Biol. 2007;45:726-731.

    Not in our library

  30. 30.

    Mahajan S.G., Mali R.G., Mehta A.A. Protective Effect of Ethanolic Extract of Seeds of Moringa oleifera Lam. Against Inflammation Associated with Development of Arthritis in Rats. J. Immunotoxicol. 2007;4:39-47.

    Not in our library10.1080/15476910601115184

  31. 31.

    Rathi B.S., Bodhankar S.L., Baheti A.M. Evaluation of aqueous leaves extract of Moringa oleifera Linn for wound healing in albino rats. Indian J. Exp. Biol. 2006;44:898-901.

    Not in our library

  32. 32.

    Bhattacharya A., Tiwari P., Sahu P.K., Kumar S. A review of the phytochemical and pharmacological characteristics of Moringa oleifera. J. Pharm. Bioallied Sci. 2018;10:181-191.

    Not in our library10.4103/jpbs.jpbs_126_18

  33. 33.

    Pandey A., Pandey R.D., Tripathi P., Gupta P.P., Haider J., Bhatt S., Singh A.V. Moringa oleifera Lam. (Sahijan)—A plant with a plethora of diverse therapeutic benefits: An Updated Retrospection. Int. J. Med. Aromat. 2012;1:1-8.

    Not in our library10.4172/2167-0412.1000101

  34. 34.

    Meireles D., Gomes J., Lopes L. A review of properties, nutritional and pharmaceutical applications of Moringa oleifera: Integrative approach on conventional and traditional Asian medicine. Adv. Tradit. Med. 2020;20:495-515.

    Not in our library10.1007/s13596-020-00468-0

  35. 35.

    Liu W.L., Wu B.F., Shang J.H., Wang X.F., Zhao Y.L., Huang A.X. Moringa oleifera seed ethanol extract and its active component kaempferol potentiate pentobarbital-induced sleeping behaviours in mice via a GABAergic mechanism. Pharm. Biol. 2022;60:810-824.

    Not in our library10.1080/13880209.2022.2056207

  36. 36.

    Gothai S., Arulselvan P., Tan W.S., Fakurazi S. Wound healing properties of ethyl acetate fraction of Moringa oleifera in normal human dermal fibroblasts. J. Intercult. Ethnopharmacol. 2016;5:1-6.

    Not in our library10.5455/jice.20160201055629

  37. 37.

    Toma A., Deyno S. Phytochemistry and pharmacological activities of Moringa oleifera. Indian, J. Pharmacol. 2014;4:222-231.

    Not in our library

  38. 38.

    Tripathi B. Charaka Samhita, of Agnivesa. 1994;15-20.

    Not in our library

  39. 39.

    Gupta K.A. Astanga Hridaya. 2000;5-17.

    Not in our library

  40. 40.

    Sharma H.R. Kashyap Samhita. 2010;2-4.

    Not in our library

  41. 41.

    Srikanthmurthy K.R. SharangadharaSamhita. 1933;14-20.

    Not in our library

  42. 42.

    Laksmipati V.S. Yogaratnakara. 1999;1-5.

    Not in our library

  43. 43.

    Mishra G., Singh P., Verma R., Kumar S., Srivastav S., Jha K.K., Khosa R.L. Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: An overview. Der Pharmacia Lett. 2011;3:141-164.

    Not in our library

  44. 44.

    Upadhyay P., Yadav M.K., Mishra S., Sharma P., Purohit S. Moringa oleifera: A review of the medical evidence for its nutritional and pharmacological properties. Int. J. Res. Pharm. Sci. 2015;5:12-16.

    Not in our library

  45. 45.

    Singh A., Navneet. Ethnomedicinal, pharmacological and antimicrobial aspects of Moringa oleifera lam.: A review. J. Phytopharmacol. 2018;7:45-50.

    Not in our library10.31254/phyto.2018.7110

  46. 46.

    Banik S., Biswas S., Karmakar S. Extraction, purification, and activity of protease from the leaves of Moringa oleifera. F1000Research. 2018;7:1151.

    Not in our library10.12688/f1000research.15642.1

  47. 47.

    Parvathy M.V.S., Umamaheshwari A. Cytotoxic Effect of Moringa oleifera Leaf Extracts on Human Multiple Myeloma Cell Lines. Trends Medical Res. 2007;2:44-50.

    Not in our library

  48. 48.

    Venkatesh N., Devi K.G., Venkateswarlu G., Sudhakar A.M.S. effect of hydroalcoholic extract of Moringa oleifera leaves on fertility hormone and sperm quality of male albino rats. Int. J. Curr. Med. Pharm. Res. 2019;1:83-87.

    Not in our library

  49. 49.

    Balogun T.A., Buliamimu K.D., Chukwudozie O.S., Tiamiyu Z.A., Idowu T.J. Anticancer Potential of Moringa oleifera on BRCA-1 Gene: Systems Biology. Bioinform. Biol. Insights. 2021;15:11779322211010703.

    Not in our library10.1177/11779322211010703

  50. 50.

    Alam P., Elkholy S.F., Mahfouz S.A., Alam P., Sharaf-Eldin M.A. HPLC based estimation and extraction of rutin, quercetin and gallic acid in Moringa oleifera plants grown in Saudi Arabia. J. Chem. Pharm. 2016;8:1243-1246.

    Not in our library

  51. 51.

    Singh B.N., Singh B.R., Singh R.L. Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera. Food Chem. Toxicol. 2009;47:1109-1116.

    Not in our library10.1016/j.fct.2009.01.034

  52. 52.

    Ndong M., Uehara M., Katsumata S., Suzuki K. Effects of oral administration of Moringa oleifera Lam on glucose tol-erance in Goto-Kakizaki and Wistar rats. J. Clin. Biochem. Nutri. 2007;40:229-233.

    Not in our library10.3164/jcbn.40.229

  53. 53.

    Zhang M., Hettiarachchy S.N., Horax R., Kannan A., Praisoody M.D.A., Muhundan A., Mallangi C.R. Phytochemicals, antioxidant and antimicrobial activity of Hibiscus sabdariffa, Centella asiatica, Moringa oleifera and Murraya koenigii leaves. J. Med. Plants Res. 2011;5:6672-6680.

    Not in our library

  54. 54.
  55. 55.

    Sharifi-Rad J., Quispe C., Castillo C.M.S., Caroca R., Lazo-Vélez M.A., Antonyak H., Polishchuk A., Lysiuk R., Oliinyk P., Masi L.D., et al. Phytochemicals for the Prevention and Treatment of Oxidative Stress-Induced Diseases. World J. Gastrointest. Endosc. 2022;22:1-9.

    Not in our library

  56. 56.

    Zduńska K., Dana A., Kolodziejczak A., Rotsztejn H. Antioxidant Properties of Ferulic Acid and Its Possible Application. Skin Pharmacol. Physiol. 2018;31:332-336.

    Not in our library10.1159/000491755

  57. 57.

    Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: Complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004;18:1670-1681.

    Not in our library10.1096/fj.04-2126com

  58. 58.

    Pandi A., Kalappan V.M. Pharmacological and therapeutic applications of Sinapic acid—An updated review. Mol. Biol. Rep. 2021;48:3733-3745.

    Not in our library10.1007/s11033-021-06367-0

  59. 59.

    Alhakmani F., Kumar S., Khan S.A. Estimation of total phenolic content, in-vitro antioxidant and anti-inflammatory activity of flowers of Moringa oleifera. Asian Pac. J. Trop. Biomed. 2013;3:623-627.

    Not in our library10.1016/s2221-1691(13)60126-4

  60. 60.

    Bennour N., Mighri H., Eljani H., Zammouri T., Akrout A. Effect of Solvent Evaporation Method on Phenolic Compounds and the Antioxidant Activity of Moringa oleifera Cultivated in Southern Tunisia. S. Afr. J. Bot. 2020;129:181-190.

    Not in our library10.1016/j.sajb.2019.05.005

  61. 61.
  62. 62.
  63. 63.

    Liao P.-C., Lai M.-H., Hsu K.-P., Kuo Y.-H., Chen J., Tsai M.-C., Li C.-X., Yin X.-J., Jeyashoke N., Chao L.K.-P. Identification of β-Sitosterol as in Vitro Anti-Inflammatory Constituent in Moringa oleifera. J. Agric. Food Chem. 2018;66:10748-10759.

    Not in our library10.1021/acs.jafc.8b04555

  64. 64.

    Sari K., Sirajuddin S., Maddeppungeng M., Hadju V., Saleh A., Hastuti H. Moringa oleifera Intake during Pregnancy and Breastfeeding toward Docosahexaenoic Acid and Arachidonic Acid Levels in Breast Milk. Open Access Maced. J. Med. Sci. 2020;8:757-761.

    Not in our library10.3889/oamjms.2020.4614

  65. 65.

    Snehal M., Parag G., Jyotsna W., Satyanarayan N.N. Intensified synthesis of structured lipids from oleic acid rich moringa oil in the presence of supercritical CO2. Food Bioprod. Process. 2020;112:86-95.

    Not in our library

  66. 66.

    Kaur G., Invally M., Sanzagiri R., Buttar H.S. Evaluation of the antidepressant activity of Moringa oleifera alone and in combination with fluoxetine. J. Ayurveda Integr. Med. 2015;6:273-279.

    Not in our library10.4103/0975-9476.172384

  67. 67.
  68. 68.

    Rue E.A., Rush M.D., Van Breemen R.B. Procyanidins: A comprehensive review encompassing structure elucidation via mass spectrometry. Phytochem. Rev. 2018;17:1-16.

    Not in our library10.1007/s11101-017-9507-3

  69. 69.

    Maurya S.K., Singh A.K. Clinical Efficacy of Moringa oleifera Lam. Stems Bark in Urinary Tract Infections. Int. Sch. Res. Not. 2014;2014:906843.

    Not in our library10.1155/2014/906843

  70. 70.

    Padla E.P., Solis L.T., Levida R.M., Shen C.C., Ragasa C.Y. Antimicrobial isothiocyanates from the seeds of Moringa oleifera Lam. Z. Für Nat. C. 2012;67:557-564.

    Not in our library10.1515/znc-2012-11-1205

  71. 71.

    Ahmadua T., Ahmad K., Ismail S.I., Rashed O., Asib N., Omar D. Antifungal efficacy of moringa oliefera leaves and seed extract against Botrytis cinerea causing graymold disease of tomato. Braz. J. Biol. 2020;81:1007-1022.

    Not in our library10.1590/1519-6984.233173

  72. 72.

    Moodley J.S., Krishna S.B.N., Pillay K. Green synthesis of silver nanoparticles from Moringa oleifera leaf extracts and its antimicrobial potential. Adv. Nat. Sci. Nanosci. Nanotechnol. 2018;9:1-10.

    Not in our library10.1088/2043-6254/aaabb2

  73. 73.

    Dinesha B.L., Nidoni U., Ramachandra. C.T., Naik N., Sankalpa K.B. Effect of extraction methods on physicochemical, nutritional, antinutritional, antioxidant and antimicrobial activity of Moringa (Moringa oleifera Lam.) seed kernel oil. J. Appl. Nat. Sci. 2018;10:287-295.

    Not in our library10.31018/jans.v10i1.1619

  74. 74.

    Anzano A., De Falco B., Ammar M., Ricciardelli A., Grauso L., Sabbah M., Capparelli R., Lanzotti V. Chemical Analysis and Antimicrobial Activity of Moringa oleifera Lam. Leaves and Seeds. Molecules. 2022;27:8920.

    Not in our library10.3390/molecules27248920

  75. 75.

    Tan W.S., Arulselvan P., Karthivashan G., Fakurazi S. Moringa oleifera Flower Extract Suppresses the Activation of Inflammatory Mediators in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages via NF-κB Pathway. Mediators Inflamm. 2015;2015:720171.

    Not in our library10.1155/2015/720171

  76. 76.

    Cuellar-Núñez M.L., Gonzalez de Mejia E., Loarca-Piña G. Moringa oleifera leaves alleviated inflammation through downregulation of IL- 2, IL- 6, and TNF- α in a colitis associated colorectal cancer model. Int. Food Res. J. 2021;144:110318.

    Not in our library10.1016/j.foodres.2021.110318

  77. 77.

    Abdel-Daim M.M., Khalil S.R., Awad A., Abu Zeid E.H., El-Aziz R.A., El-Serehy H.A. Ethanolic Extract of Moringa oleifera Leaves Influences NF-κB Signaling Pathway to Restore Kidney Tissue from Cobalt-Mediated Oxidative Injury and Inflammation in Rats. Nutrients. 2020;12:1031.

    Not in our library10.3390/nu12041031

  78. 78.

    Choi E.J., Debnath T., Tang Y., Ryu Y.B., Moon S.H., Kim E.K. Topical application of Moringa oleifera leaf extract ameliorates experimentally induced atopic dermatitis by the regulation of Th1/Th2/Th17 balance. Biomed. Pharmacother. 2016;84:870-877.

    Not in our library10.1016/j.biopha.2016.09.085

  79. 79.

    Soliman M.M., Al-Osaimi S.H., Hassan Mohamed E., Aldharani A., Alkhedaide A., Althobaiti F., Mohamed W.A. Protective effects of Moringa oleifera Leaf Extract against Methotrexate-Induced Oxidative Stress and Apoptosis on Mouse Spleen. Evid. -Based Complement. Altern. Med. 2020;2020:6738474.

    Not in our library10.1155/2020/6738474

  80. 80.

    Zhou Y., Yang W., Li Z., Luo D., Li W., Zhang Y., Wang X., Fang M., Chen Q., Jin X. Moringa oleifera stem extract protect skin keratinocytes against oxidative stress injury by enhancement of antioxidant defense systems and activation of PPARα. Biomed. Pharmacother. 2018;107:44-53.

    Not in our library10.1016/j.biopha.2018.07.152

  81. 81.

    El-Hadary A.E., Ramadan M.F. Antioxidant traits and protective impact of Moringa oleifera leaf extract against diclofenac sodium-induced liver toxicity in rats. J. Food Biochem. 2019;43:e12704.

    Not in our library10.1111/jfbc.12704

  82. 82.

    Nunthanawanich P., Sompong W., Sirikwanpong S., Mäkynen K., Adisakwattana S., Dahlan W., Ngamukote S. Moringa oleifera aqueous leaf extract inhibits reducing monosaccharide-induced protein glycation and oxidation of bovine serum albumin. Springer Plus. 2016;5:1098.

    Not in our library10.1186/s40064-016-2759-3

  83. 83.

    Albuquerque Costa R., de Sousa O.V., Hofer E., Mafezoli J., Barbosa F.G., Vieira R. Thiocarbamates from Moringa oleifera Seeds Bioactive against Virulent and Multidrug-Resistant Vibrio Species. BioMed Res. Int. 2017;2017:7963747.

    Not in our library10.1155/2017/7963747

  84. 84.
  85. 85.

    Agrawal N.D., Nirala S.K., Shukla S., Mathur R. Co-administration of adjuvants along with Moringa oleifera attenuates beryllium-induced oxidative stress and histopathological alterations in rats. Pharm. Biol. 2015;53:1465-1473.

    Not in our library10.3109/13880209.2014.986685

  86. 86.

    Sasikala V., Rooban B.N., Priya S.G., Sahasranamam V., Abraham A. Moringa oleifera prevents selenite-induced cataractogenesis in rat pups. J. Ocul. Pharmacol. Ther. 2010;26:441-447.

    Not in our library10.1089/jop.2010.0049

  87. 87.

    Vongsak B., Mangmool S., Gritsanapan W. Antioxidant Activity and Induction of mRNA Expressions of Antioxidant Enzymes in HEK-293 Cells of Moringa oleifera Leaf Extract. Planta Med. 2015;81:1084-1089.

    Not in our library10.1055/s-0035-1546168

  88. 88.

    Mohd Fisall U.F., Ismail N.Z., Adebayo I.A., Arsad H. Dichloromethane fraction of Moringa oleifera leaf methanolic extract selectively inhibits breast cancer cells (MCF7) by induction of apoptosis via upregulation of Bax, p53 and caspase 8 expressions. Mol. Biol. Rep. 2021;48:4465-4475.

    Not in our library10.1007/s11033-021-06466-y

  89. 89.

    Attah A.F., Moody J.O., Sonibare M.A., Salahdeen H.H., Akindele O.O., Nnamani P.O., Diyaolu O.A., Raji Y. Aqueous extract of Moringa oleifera leaf used in Nigerian ethnomedicine alters conception and some pregnancy outcomes in Wistar rat. S. Afr. J. Bot. 2020;129:255-262.

    Not in our library10.1016/j.sajb.2019.07.041

  90. 90.

    Sharifudin S.A., Fakurazi S., Hidayat M.T., Hairuszah I., Aris M., Moklas M., Arulselvan P. Therapeutic potential of Moringa oleifera extracts against acetaminophen-induced hepatotoxicity in rats. Pharm. Biol. 2013;51:279-288.

    Not in our library10.3109/13880209.2012.720993

  91. 91.

    Hamza A.A. Ameliorative effects of Moringa oleifera Lam seed extract on liver fibrosis in rats. Food Chem. Toxicol. 2010;48:345-355.

    Not in our library10.1016/j.fct.2009.10.022

  92. 92.

    Nandave M., Ojha S.K., Joshi S., Kumari S., Arya D.S. Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: Evidence for an antioxidant, antiperoxidative, and cardioprotective intervention. J. Med. Food. 2009;12:47-55.

    Not in our library10.1089/jmf.2007.0563

  93. 93.

    Panda S., Kar A., Sharma P., Sharma A. Cardioprotective potential of N,alpha-L-rhamnopyranosyl vincosamide, an indole alkaloid, isolated from the leaves of Moringa oleifera in isoproterenol induced cardiotoxic rats: In vivo and in vitro studies. Bioorganic Med. Chem. Lett. 2012;23:959-962.

    Not in our library10.1016/j.bmcl.2012.12.060

  94. 94.

    Ijioma S.N., Nwaogazi E.N., Nwankwo A.A., Oshilonya H., Ekeleme C.M., Oshilonya L.U. Histological exhibition of the gastroprotective effect of Moringa oleifera leaf extract. Comp. Clin. Pathol. 2018;27:327-332.

    Not in our library10.1007/s00580-017-2594-0

  95. 95.

    Mallya R., Chatterjee P.K., Vinodini N.A., Chatterjee P., Mithra P. Moringa oleifera Leaf Extract: Beneficial Effects on Cadmium Induced Toxicities—A review. J. Clin. Diagn. Res. 2017;11:CE01.

    Not in our library10.7860/jcdr/2017/21796.9671

  96. 96.

    Martínez-Gonzálezb C.L., Martíneza L., Martínez-Ortizb E.J., González-Trujanoa M.E., Déciga-Camposc M., Ventura-Martínezd R., Díaz-Revale I. Moringa oleifera, a species with potential analgesic and anti-inflammatory activities. Biomed. Pharmacother. 2017;87:482-488.

    Not in our library10.1016/j.biopha.2016.12.107

  97. 97.

    Mohan M., Kaul N., Punekar A., Girnar R., Junnare P., Patil L. Nootropic activity of Moringa oleifera leaves. J. Nat. Remedies. 2005;5:59-62.

    Not in our library

  98. 98.

    Amrutia J.N., Lala M., Srinivasa U., Shabaraya A.R., Semuel M.R. Anticonvulsant activity of Moringa oleifera leaf. Int. Res. J. Pharm. 2011;2:160-162.

    Not in our library

  99. 99.

    Ray K., Guha D. Effect of Moringa oleifera root extract on penicillin-induced epileptic rats. Biog. Amines. 2005;19:223-231.

    Not in our library10.1163/156939105774288780

  100. 100.

    Khongrum J., Wattanathorn J., Muchimapura S., Thukhum-mee W., Thipkaew C., Wannanon P., Tong-Un T. Moringa oleifera Leaves Extract Attenuates Neuropathic Pain Induced by Chronic Constriction Injury. Am. J. Appl. Sci. 2012;9:1182-1187.

    Not in our library

  101. 101.

    Raafat K., Hdaib F. Neuroprotective Effects of Moringa oleifera: Bio-guided GC-MS Identification of Active Compounds in Diabetic Neuropathic Pain Model. Chin. J. Integr. Med. 2017.

    Not in our library10.1007/s11655-017-2758-4

  102. 102.

    Muhammad A.A., Arulselvan P., Cheah P.S., Abas F., Fakurazi S. Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. Drug Des. Devel. Ther. 2016;10:1715-1730.

    Not in our library10.2147/dddt.s96968

  103. 103.

    Awodele O., Oreagba I.A., Odoma S., Jaime A., Da Silva T., Osunkalu V.O. Toxicological evaluation of the aqueous leaf extract of Moringa oleifera Lam. (Moringaceae). J. Ethnopharmacol. 2012;139:330-336.

    Not in our library10.1016/j.jep.2011.10.008

  104. 104.

    Mehwish H.M., Rajoka M.S., Xiong Y., Zheng K., Xiao H., Liu Z., Zhu Q., He Z. Moringa oleifera—A Functional Food and Its Potential Immunomodulatory Effects. Food Rev. Int. 2020;38:1533-1552.

    Not in our library10.1080/87559129.2020.1825479

  105. 105.

    Suzana D., Suyatna F.D., Andrajati R., Sari S.P., Mun’im A. Effect of Moringa oleifera leaves extract against hematology and blood biochemical value of patients with iron deficiency anaemia. J. Young Pharm. 2017;9:79-84.

    Not in our library10.5530/jyp.2017.1s.20

  106. 106.

    Bais S., Singh G.S., Sharma R. Anti-obesity and hypolipidemic activity of Moringa oleifera leaves against high fat diet-induced obesity in rats. Adv Biol. 2014;2014:162914.

    Not in our library10.1155/2014/162914

  107. 107.

    Redha A.A., Perna S., Riva A., Petrangolini G., Peroni G., Nichetti M., Iannello G., Naso M., Faliva M.A., Rondanelli M. Novel insights on anti-obesity potential of the miracle tree, Moringa oleifera: A systematic review. J. Funct. Foods. 2021;84:104600.

    Not in our library10.1016/j.jff.2021.104600

  108. 108.

    Al-maliki A., El Rabey H.A. The Antidiabetic Effect of Low Doses of Moringa oleifera Lam. Seeds on Streptozotocin Induced Diabetes and Diabetic Nephropathy in Male Rats. Biomed Res. Int. 2015;2015:381040.

    Not in our library10.1155/2015/381040

  109. 109.

    Villarruel-López A., López-de la Mora D.A., Vázquez-Paulino O.D., Puebla-Mora A.G., Torres-Vitela M.R., Guerrero-Quiroz L.A., Nuño K. Effect of Moringa oleifera consumption on diabetic rats. BMC Complement. Altern. Med. 2018;18:120-127.

    Not in our library10.1186/s12906-018-2180-2

  110. 110.

    Azad S.B., Ansari P., Azam S., Hossain S.M., Shahid M.I., Hasan M., Hannan J. Anti-hyperglycaemic activity of Moringa oleifera is partly mediated by carbohydrase inhibition and glucose-fibre binding. Biosci. Rep. 2017;37:BSR20170059.

    Not in our library10.1042/bsr20170059

  111. 111.

    Khan H., Jaiswal V., Kulshreshtha S., Khan A. Potential Angiotensin Converting Enzyme Inhibitors from Moringa oleifera. Recent Patents Biotechnol. 2019;13:239-248.

    Not in our library10.2174/1872208313666190211114229

  112. 112.

    Khan H., Hussain T., Kataria M., Seth A., Malik M., Dash A., Chand S., Khan M. Role of selective Bioactive Compounds as an Angiotensin Converting Enzyme Inhibitor. Res. Sq. 2020;7:1-25.

    Not in our library

  113. 113.

    Adeyi A.O., Ajisebiola S.B., Adeyi E.O., Alimba C.G., Okorie U.G. Antivenom activity of Moringa oleifera leave against pathophysiological alterations, somatic mutation and biological activities of Naja nigricollis venom. Sci. Afr. 2020;8:68-76.

    Not in our library10.1016/j.sciaf.2020.e00356

  114. 114.

    Nayak G., Rao A., Mullick P., Mutalik S., Kalthur S.G., Adiga S.K., Kalthur G. Ethanolic extract of Moringa oleifera leaves alleviate cyclophosphamide induced testicular toxicity by improving endocrine function and modulating cell specific gene expression in mouse testis. J Ethnopharmacol. 2020;259:112922.

    Not in our library10.1016/j.jep.2020.112922

  115. 115.

    Adedapo A.A., Mogbojuri O.M., Emikpe B.O. Safety evaluations of the aqueous extract of the leaves of Moringa oleifera in rats. J. Med. Plant Res. 2009;3:586-591.

    Not in our library

  116. 116.

    Ajibade T.O., Arowolo R., Olayemi F.O. Phytochemical screening and toxicity studies on the methanol extract of the seeds of Moringa oleifera. J. Complement. Integr. Med. 2013;10:11-16.

    Not in our library10.1515/jcim-2012-0015

  117. 117.

    Reddy Y.R.R., Lokanatha O., Ratnam K.S.V.P., Reddy C.S., Raju I.S., Reddy C.D. Acute and Sub Acute Toxicity of Moringa oleifera Stem Bark Extract in Swiss Albino Mice. IJLBPR. 2013;2:73-82.

    Not in our library

  118. 118.

    Asiedu-Gyekye I.J., Frimpong-Manso S., Awortwe C., Antwi D.A., Nyarko A.K. Micro- and Macroelemental Composition and Safety Evaluation of the Nutraceutical Moringa oleifera Leaves. J Toxicol. 2014;2014:786979.

    Not in our library10.1155/2014/786979

  119. 119.

    US National Library of Medicine. Clinicaltrial.gov.

    Not in our library

  120. 120.

    Sathyavathi R., Krishna M.B.M., Rao D.N. Biosynthesis of Silver Nanoparticles Using Moringa oleifera Leaf Extract and Its Application to Optical Limiting. J. Nanosci. Nanotechnol. 2011;11:2031-2035.

    Not in our library10.1166/jnn.2011.3581

  121. 121.

    Devaraj V.C., Krishna B. Antiulcer activity of a polyherbal formulation (PHF) from indian medicinal plants. Chin. J. Nat. Med. 2013;11:145-148.

    Not in our library10.1016/s1875-5364(13)60041-2

  122. 122.

    Yadav J.S., Shah B.N., Gupta A., Shah D.P. Development and evaluation of polyherbal ointments for anti-inflammatory therapy. Int. J. Pharm. Res. 2014;6:114-119.

    Not in our library

  123. 123.

    Vibhute S., Kasture V., Kasture S., Kendre P., Rupnar S., Pande V. Design and characterization of Moringa oleifera seed oil impregnated anti-inflammatory topical micro-dispersion. Der Pharmacia Lett. 2015;7:7-16.

    Not in our library

  124. 124.

    Panya T., Chansri N., Daodee S. Development and evaluation of lozenge from Moringa oleifera leaf extract. Res. J. Pharm. Technol. 2016;9:805-809.

    Not in our library10.5958/0974-360x.2016.00154.2

  125. 125.

    Abd-Rabou A.A., Zoheir K.M.A., Kishta M.S., Shalby A.B., Ezzo M.I. Nano-micelle of Moringa oleifera seed oil triggers mitochondrial cancer cell apoptosis. Asian Pac. J. Cancer Prev. 2016;17:4929-4933.

    Not in our library10.22034/apjcp.2016.17.11.4929

  126. 126.

    Srivastava R., Srivastava S., Singh S.P. Thermoreversible in-situ nasal gel formulations and their pharmaceutical evaluation for the treatment of allergic rhinitis containing extracts of moringa olifera and embelia ribes. Int. J. Pharm. 2017;9:16-20.

    Not in our library10.22159/ijap.2017v9i6.18780

  127. 127.

    Chin C., Jalil J., Ng P.Y., Ng S. Development and formulation of Moringa oleifera standardised leaf extract film dressing for wound healing application. J. Ethnopharmacol. 2018;212:188-199.

    Not in our library10.1016/j.jep.2017.10.016

  128. 128.

    Murdiana H.E., Revika E., Rahmawati D., Puspitasari T.R., Putri A.D., Murti B.T. Moringa oleifera lam. based effervescent tablets: Design, formulation and physicochemical evaluation. Int. J. Drug Deliv. Technol. 2018;8:222-228.

    Not in our library

  129. 129.

    Suryadevara V., Doppalapudi S., Sasidhar Reddivallam L., Anne R., Mudda M. Formulation and evaluation of anti-inflammatory cream by using Moringa oleifera seed oil. Pharmacogn. Res. 2018;10:195-204.

    Not in our library10.4103/pr.pr_101_17

  130. 130.

    Komal Labh A., Rajeshkumar S., Roy A., Santhoshkumar J., Lakshmi T. Herbal formulation mediated synthesis of silver nanoparticles and its antifungal activity against candida albicans. Indian J. Public Health Res. Dev. 2019;10:3454-3458.

    Not in our library10.5958/0976-5506.2019.04117.2

  131. 131.

    Chin C., Ng P., Ng S. Moringa oleifera standardised aqueous leaf extract-loaded hydrocolloid film dressing: In vivo dermal safety and wound healing evaluation in STZ/HFD diabetic rat model. Drug Deliv. Transl. Res. 2019;9:453-468.

    Not in our library10.1007/s13346-018-0510-z

  132. 132.

    Srivastava R., Srivastava S., Singh S.P. Comparative study of anti-allergic activity of two poly-herbal formulations in ova-challenged allergic rhinitis mice model. Orient. Pharm. Exp. Med. 2019;19:37-47.

    Not in our library10.1007/s13596-018-0345-7

  133. 133.

    Chin C., Ng S. Development of Moringa oleifera standardized leaf extract nanofibers impregnated onto hydrocolloid film as A potential chronic wound dressing. Fibers Polym. 2020;21:2462-2472.

    Not in our library10.1007/s12221-020-1356-9

  134. 134.

    Hassabo A.G., Shaarawy S., Mohamed A.L., Hebiesh A. Multifarious cellulosic through innovation of highly sustainable composites based on moringa and other natural precursors. Int. J. Biol. Macromol. 2020;165:141-155.

    Not in our library10.1016/j.ijbiomac.2020.09.125

  135. 135.

    Pagano C., Perioli L., Baiocchi C., Bartoccini A., Beccari T., Blasi F., Ricci M. Preparation and characterization of polymeric microparticles loaded with Moringa oleifera leaf extract for exuding wound treatment. Int. J. Pharm. 2020;587:119700.

    Not in our library10.1016/j.ijpharm.2020.119700

  136. 136.

    Aisida S.O., Madubuonu N., Alnasir M.H., Ahmad I., Botha S., Maaza M., Ezema F.I. Biogenic synthesis of iron oxide nanorods using Moringa oleifera leaf extract for antibacterial applications. Appl. Nanosci. 2020;10:305-315.

    Not in our library10.1007/s13204-019-01099-x

  137. 137.

    Isimi C.Y., John-Africa L.B., Ekere K.E., Olayemi O.J., Aremu O.I., Emeje M.O. Formulation, evaluation and anti-hemorroidal activity of suppositories containing Moringa oleifera lam. seed oil. Acta Pharm. Sci. 2021;59:647-665.

    Not in our library10.23893/1307-2080.aps.05907

  138. 138.

    Aristianti A., Nurkhaeri N., Tandiarrang V.Y., Awaluddin A., Muslimin L. Formulation and pharmacological studies of leaves of moringa (Moringa oleifera), a novel hepatoprotection in oral drug formulations. Open Access Maced. J. Med. Sci. 2021;9:151-156.

    Not in our library10.3889/oamjms.2021.5839

  139. 139.

    Alsammarraie H.J.M., Khan N.A.K., Mahmud R. Formulation, evaluation, and in vivo anti-inflammatory and anti-arthritic activities of moringa granules. Int. J. Appl. Pharm. 2021;13:112-120.

    Not in our library10.22159/ijap.2021v13i3.40478

  140. 140.

    Rani K.C., Hasanah T.U., Ilmiah B., Jayani N.I.E. Formulation of moringa extract chewable gummy tablet with na-alginate and pectin as carriers. Res. J. Pharm. Technol. 2022;15:2513-2520.

    Not in our library10.52711/0974-360x.2022.00420

  141. 141.

    Ali A., Garg P., Goyal R., Kaur G., Li X., Negi P., Valis M., Kuca K., Kulshrestha S. A Novel Herbal Hydrogel Formulation of Moringa oleifera for Wound Healing. Plants. 2020;10:25.

    Not in our library10.3390/plants10010025

  142. 142.

    Wanjiru J., Gathirwa J., Sauli E., Swai H.S. Formulation, optimization, and evaluation of Moringa oleifera leaf polyphenol-loaded phytosome delivery system against breast cancer cell lines. Molecules. 2022;27:4430.

    Not in our library10.3390/molecules27144430

  143. 143.

    Iskandar B., Novita G., Annisa F.F., Leny Hafiz I., Surboyo M.D.C., Lee C. Evaluation of physical quality and antioxidant activity of ethanol extract of moringa leaves (Moringa oleifera LAM) formulated in emulgel preparation. Res. J. Pharm. Technol. 2022;15:2703-2708.

    Not in our library10.52711/0974-360x.2022.00452

  144. 144.

    Engsuwana J., Waranuch N., Limpeanchob N., Ingkaninan K. HPLC methods for quality control of Moringa oleifera extract using isothiocyanates and astragalin as bioactive markers. Scienceasia. 2017;43:169-174.

    Not in our library10.2306/scienceasia1513-1874.2017.43.169

  145. 145.

    Yadav V., Ahmad S., Zahra K. Assessment of the protective effects of Moringa oleifera leaf extract against Neem- Oil induced toxicity in zebra fish, Danio rerio. J. Pharmacogn. Phytochem. 2019;8:4263-4270.

    Not in our library

  146. 146.

    Kanchani A., Harris K.D. Effect of Foliar Application of Moringa (Moringa oleifera) Leaf Extract with Recommended Fertilizer on Growth and Yield of Okra (Abelmoschus Esculentus). J. Agric. Sci. 2019;13:38-54.

    Not in our library10.4038/agrieast.v13i2.73

  147. 147.

    Manzoor M., Ali H., Muhammad A., Alam I., Khalid S.H., Idrees A., Arif M. Potential of Moringa (Moringa oleifera: Moringaceae) as plant growth regulator and bio-Pesticide against wheat aphids on wheat crop (Triticum aestivum; Poaceae). J. Biopestic. 2015;8:120-127.

    Not in our library

  148. 148.

    Arif Y., Bajguz A., Hayat S. Moringa oleifera Extract as a Natural Plant Biostimulant. J. Plant Growth Regul. 2022.

    Not in our library10.1007/s00344-022-10630-4

  149. 149.

    Hassarajani S., Souza T.D., Mengi S.A. Efficacy study of the bioactive fraction (F-3) of Acorus calamus in hyperlipidemia. Indian J. Pharmacol. 2007;39:196-200.

    Not in our library

  150. 150.

    Randriamboavonjy J.I., Rio M., Pacaud P., Loirand G., Tesse A. Moringa oleifera seeds attenuate vascular oxidative and nitrosative stresses in spontaneously hypertensive rats. Oxid. Med. Cell. Longev. 2017;2017:4129459.

    Not in our library10.1155/2017/4129459

  151. 151.

    Halaby M.S., Metwally E.M., Omar A.A. Effect of Moringa oleifera on serum lipids and kidney function of hyperlipidaemic rats. Res. J. Appl. Sci. 2013;9:5189-5198.

    Not in our library

  152. 152.

    Karim N.A., Ibrahim M.D., Kntayya S.B., Rukayadi Y., Hamid H.A., Razis A.F. Moringa oleifera Lam: Targeting Chemoprevention. Asian Pac. J. Cancer Prev. 2016;17:3675-3686.

    Not in our library

  153. 153.

    Ganguly R., Hazra R., Ray K., Guha D. Effect of Moringa oleifera in experimental model of Alzheimer’s disease: Role of antioxidants. Ann. Neurosci. 2005;12:36-39.

    Not in our library10.5214/ans.0972.7531.2005.120301

  154. 154.

    Giacoipo S., Rajan T.S., De Nicola G.R., Iori R., Rollin P., Bramanti P., Mazzon E. The Isothiocyanate Isolated from Moringa oleifera Shows Potent Anti-Inflammatory Activity in the Treatment of Murine Subacute Parkinson’s Disease. Rejuvenation Res. 2017;20:50-63.

    Not in our library10.1089/rej.2016.1828

  155. 155.

    Palomares-Alonso F., Jung H., Vidal-Cantú G.C., Tomé R., Susana I., Esquivel G., Dinora F., Cruz D.L., Pérez V., González I., et al. Moringa oleifera Extracts and Praziquantel Combination: Bioavailability in Rats and Cysticidal Activity in a Murine Model. Rev. Bras. Farmacogn. 2020;30:251-256.

    Not in our library10.1007/s43450-020-00058-w

  156. 156.

    Kawada N., Seki S., Inoue M., Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupfer cells. Hepatology. 1998;27:1265-1274.

    Not in our library10.1002/hep.510270512

  157. 157.

    Ferreira P.M.P., Farias D.F., de Abreu Oliveira J.T., de Fátima Carvalho A. Moringa oleifera: Bioactive compounds and nutritional potential. Rev. Nutr. 2008;21:1-10.

    Not in our library10.1590/s1415-52732008000400007

  158. 158.

    Paul S., Basak P., Majumder R., Mukherjee A., Ghosh J., Patra S., Jana N.K. Biochemical estimation of Moringa oleifera leaf extract for synthesis of silver nanoparticle mediated drug delivery system. J. Plant Biochem. Biotechnol. 2019;29:86-93.

    Not in our library10.1007/s13562-019-00517-z

  159. 159.
  160. 160.

    Tolba H., Elmaaty A., Farag G., Mansour D., El-akkad H. Immunological effect of Moringa oleifera leaf extract on vaccinated and non-vaccinated Hubbard chickens experimentally infected with Newcastle virus. Saudi J. Biol. Sci. 2021;29:420-426.

    Not in our library10.1016/j.sjbs.2021.09.012

  161. 161.

    Khan S., Basra S., Afzal I., Nawaz M., Rehman H.U. Growth promoting potential of fresh and stored Moringa oleifera leaf extracts in improving seedling vigor, growth and productivity of wheat crop. Environ. Sci. Pollut. Res. 1999;24:27601-27612.

    Not in our library10.1007/s11356-017-0336-0

  162. 162.

    Damilola A.M., Temitope M.F.O. Assessment of Moringa oleifera as Bio-Pesticide against Podagricaspp on the growth and yield of Okra (Abelmoschus esculentus L. Moench). J. Horttic. 2020;7:1-10.

    Not in our library

  163. 163.

    Abd El-Hack M.E., Alagawany M., Elrys A.S., Desoky E.S.M., Tolba H.M.N., Elnahal A.S.M., Elnesr S.S., Swelum A.A. Effect of Forage Moringa oleifera L. (moringa) on Animal Health and Nutrition and Its Beneficial Applications in Soil, Plants and Water Purification. Agriculture. 2018;8:145.

    Not in our library10.3390/agriculture8090145

  164. 164.

    Iqbal M.A. Response of Canola (Brassica napus L.) to Foliar Application of Moringa (Moringa olifera L.) and Brassica (Bras-sica napus L.) Water Extracts. Master’s Thesis. 2014.

    Not in our library

  165. 165.

    Nagar P.K., Iyer R.I., Sircar P.K. Cytokinins in developing fruits of Moringa pterigosperma Gaertn. Physiol. Plant. 1982;55:45-50.

    Not in our library10.1111/j.1399-3054.1982.tb00283.x

  166. 166.

    Clasen C., Mclaughlin N., Nayaar S., Boisson R., Gupta D., Shah N. Microbiological effectiveness and cost of disinfecting water by boiling in semi-urban India Am. Soc. Trop. Med. Hyg. 2008;2008:407-413.

    Not in our library10.4269/ajtmh.2008.79.407

  167. 167.

    Clasen T., Cairncross S., Haller L., Bartram J., Walker D. Cost-effectiveness of water quality interventions for preventing diarrhoeal disease in developing countries. J. Water Health. 2007;5:599-608.

    Not in our library10.2166/wh.2007.010

  168. 168.
  169. 169.

    Akinyeye J., Solanke E.O., Adebiyi I.O. Phytochemical and antimicrobial evaluation of leaf and seed of moringa olifera extracts. IJRMHS. 2014;4:2083-2307.

    Not in our library

  170. 170.

    Mahmood K.T., Mugal T., Haq I.U. Moringa oleifera: A natural gift—A review. J. Pharm. Sci. Res. 2010;2:775-781.

    Not in our library

  171. 171.

    López-Salazar H., Camacho-Díaz B.H., Ávila-Reyes S.V., Pérez-García M.D., Cortazar M.G., Ocampo M.L.A., Jiménez-Aparicio A.R. Identification and Quantification of β-Sitosterol β-d-Glucoside of an Ethanolic Extract Obtained by Microwave-Assisted Extraction from Agave angustifolia Haw. Molecules. 2019;24:3926.

    Not in our library10.3390/molecules24213926

  172. 172.

    Saini R.K., Shetty N.P., Giridhar P. Carotenoid content in vegetative and reproductive parts of commercially grown Moringa oleifera Lam. cultivars from India by LC–APCI–MS. Eur. Food Res. Technol. 2014;238:971-978.

    Not in our library10.1007/s00217-014-2174-3

  173. 173.

    Sahakitpichan P., Mahidol C., Disadee W., Ruchirawat S., Kanchanapoom T. Unusual glycosides of pyrrole alkaloid and 4′-hydroxyphenylethanamide from leaves of Moringa oleifera. Phytochemistry. 2011;72:791-795.

    Not in our library10.1016/j.phytochem.2011.02.021

  174. 174.
  175. 175.

    AbdullRazis A.F., Ibrahim M.D., Kntayya S.B. Health benefits of Moringa oleifera. Asian Pac. J. Cancer Prev. 2014;15:8571-8576.

    Not in our library10.7314/apjcp.2014.15.20.8571

  176. 176.

    Anzano A., Ammar M., Papaianni M., Grauso L., Sabbah M., Capparelli R., Lanzotti V. Moringa oleifera Lam.: A Phytochemical and Pharmacological Overview. Horticulturae. 2021;7:409.

    Not in our library10.3390/horticulturae7100409

  177. 177.

    Matic I., Guidi A., Kenzo M., Mattei M., Galgani A. Investigation of medicinal plants traditionally used as dietary supplements: A review on Moringa oleifera. J. Public Health Afr. 2018;9:841.

    Not in our library10.4081/jphia.2018.841

  178. 178.

    Bhattacharya A., Ghosh G., Agrawal D., Sahu P.K., Kumar S., Mishra S.S. GC-MS profiling of ethanolic extract of Moringa oleifera leaf. Int. J. Pharm. Bio. Sci. 2014;5:263-275.

    Not in our library

  179. 179.

    Faizi S., Siddiqui B.S., Saleem R., Siddiqui S., Aftab K. Isolation and structure elucidation of new nitrile and mustard oil glycosides from Moringa oleifera and their effect on blood pressure. J. Nat. Prod. 1994;57:1256-1261.

    Not in our library10.1021/np50111a011

  180. 180.

    Bhattacharya S.B., Das A.K., Banerji N. Chemical investigations on the gum exudate from sajna (Moringa oleifera). Carbohydr. Res. 1982;102:253-262.

    Not in our library10.1016/s0008-6215(00)88067-2

  181. 181.

    Zhu Y., Yin Q., Yang Y. Comprehensive investigation of Moringa oleifera from different regions by simultaneous determination of 11 polyphenols using UPLC-ESI-MS/MS. Molecules. 2020;25:676.

    Not in our library10.3390/molecules25030676

  182. 182.

    Vongsak B., Sithisarn P., Gritsanapan W. Simultaneous HPLC quantitative analysis of active compounds in leaves of Moringa oleifera Lam. J. Chromatogr. Sci. 2014;52:641-645.

    Not in our library10.1093/chromsci/bmt093

  183. 183.

    Yang R.Y., Lin S., Kuo G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac. J. Clin. Nutr. 2008;17((Suppl. S1)):275-279.

    Not in our library

  184. 184.

    Bajpai M., Pande A., Tewari S.K., Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int. J. Food Sci. Nutr. 2005;56:287-291.

    Not in our library10.1080/09637480500146606

  185. 185.

    Prakash D., Suri S., Upadhyay G., Singh B.N. Total phenol, antioxidant and free radical scavenging activities of some medicinal plants. Int. J. Food Sci. Nutr. 2007;58:18-28.

    Not in our library10.1080/09637480601093269

  186. 186.

    Leone A., Fiorillo G., Criscuoli F., Ravasenghi S., Santagostini L., Fico G., Spadafranca A., Battezzati A., Schiraldi A., Pozzi F., et al. Nutritional Characterization and Phenolic Profiling of Moringa oleifera Leaves Grown in Chad, Sahrawi Refugee Camps, and Haiti. Int. J. Mol. Sci. 2015;16:18923-18937.

    Not in our library10.3390/ijms160818923

  187. 187.

    Girme A., Bhoj P., Saste G. Development and Validation of RP-HPLC Method for Vicenin-2, Orientin, Cynaroside, Betulinic Acid, Genistein, and Major Eight Bioactive Constituents with LC-ESI-MS/MS Profiling in Ocimum Genus. J. AOAC Int. 2021;104:1634-1651.

    Not in our library10.1093/jaoacint/qsab067

  188. 188.

    Desai S., Tatke P., Gabhe S. Enhanced HPLC-DAD Method for Fast Determination of Quercetin-3-O-β-d-Glucoside in Extracts and Polyherbal Formulations Containing Azadirachta indica-Optimization and Validation. JOC. 2017;55:706-711.

    Not in our library10.1093/chromsci/bmx024

  189. 189.

    Faizi S., Sumbul S., Versiani M.A., Saleem R., Sana A., Siddiqui H. GC/GCMS analysis of the petroleum ether and dichloromethane extract of Moringa oleifera roots. Asian Pac. J. Trop. Biomed. 2014;4:650-654.

    Not in our library10.12980/apjtb.4.201414b141

  190. 190.

    Förster N., Ulrichs C., Schreiner M., Müller C.T., Mewis I. Development of a reliable extraction and quantification method for glucosinolates in Moringa oleifera. Food Chem. 2015;166:456-464.

    Not in our library10.1016/j.foodchem.2014.06.043

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.